News

Mustafa Diken speaks at Future Medicine 2017.

The Berlin Institute of Health, together with the Charité Universitätsmedizin Berlin, Max Delbrück Center for Molecule Medicine and Tagesspiegel, will host the second Future Medicine: Innovation in Health Science meeting on 7th November.
Read More

Honorary Medical Doctor’s Degree for Cornelis Melief

Mainz, 2017-10-25 – TRON scientific advisor Prof. Dr. Dr. Cornelis J. Melief, Leiden, Netherlands, will be awarded with the degree of an honorary medical doctor. Melief will be awarded for his lifetime achievements as a pioneer of tumor immunology, as well as for his commitment and deserts regarding immunological research in Mainz. Further information about
Read More

Ruggero Ceppellini Advanced School of Immunology

The topic of this year’s EFIS-EJI Ruggero-Ceppellini Advanced School of Immunology is “Tumour Immunology: from tissue microenvironment to immunotherapy.”
Read More

Ugur Sahin at the NCI Cancer Immunology and Immunotherapy Symposium

The National Cancer Institute’s Center of Excellence in Immunogy sponsors a two-day symposium with the theme “Cancer Immunology and Immunotherapy: From Conception to Delivery”.
Read More

Mustafa Diken speaks at Radboud UMC MMD symposium “Chemical Immunology”

The Institute for Molecular Life Sciences at Radboud University Medical Center (RIMLS) will host a mini-symposium entitled “Chemical Immunology”. 
Read More

1st Crick International Cancer Conference

The 1st Crick International Cancer Conference will bring together leading cancer scientists from all over the world to discuss the latest findings in cancer metabolism, the tumor microenvironment, and how the cancer genotype changes over time.
Read More

The Annual Meeting of the Leopoldina National Academy of Sciences

Mainz, September 23, 2017 – The Annual Meeting of the Leopoldina National Academy of Sciences will be held on 22 and 23 September in Halle (Saale).
Read More

27th German Skin Cancer Congress

Mainz, September 21, 2017 – The working group Dermatological Oncology (ADO) organizes from 21-23 September the 27th German Skin Cancer Congress in the Rheingoldhalle Mainz.
Read More

Improvement of in vivo expression of genes delivered by self-amplifying RNA using Vaccinia Virus immune evasion proteins

Among nucleic acid-based delivery platforms, self-amplifying RNA (saRNA) vectors are of increasing interest for applications such as transient expression of recombinant proteins and vaccination. Although saRNA is a promising technology, antigen expression from saRNA is limited by the host cells’ innate interferon response. TRON’s Tim Beissert and colleagues show, in an upcoming issue of Human
Read More

Seminar in Translational Oncology – Prof. Federico Garrido

Mainz, September 2017 – Am 14. September kommt im Rahmen der Seminarreihe in Translational Oncology (SITO) Prof. Federico Garrido der Universität von Granada Medical School nach Mainz. Sie sind herzlich zu seinem Vortrag um 17.00 Uhr c.t. in Gebäude 708 der Universitätsmedizin Mainz eingeladen.
Read More

Individualized cancer immunotherapy

Mainz, September 6, 2017 – Individualized cancer immunotherapy Prof. Ugur Sahin, Managing Director (Science and Research) and Co-Founder of TRON, will talk at the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in our hometown Mainz. His talk is titled “Individualized Cancer Immunotherapy – Exploring a new landscape” and will cover the implementation of an RNA-based approach
Read More

THIRD CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE

Mainz, September 2017 – TRON will also participate at the THIRD CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE in Mainz this year. Meet and talk to our experts in: Bioinformatics: Wednesday, 12:30-2:00 pm Next Generation Sequencing: Wednesday, 3:00-4:00 pm Biomarker: Thursday, 11:30-1:00 pm Immunomonitoring: Thursday, 3:00-4:00 pm Pre-Clinical Research: Friday, 12:30-2:00 pm T-cell Vaccines & Immunotherapy: Friday,
Read More

TRON Seminars in Translational Oncology: Dr. Evan Newell

Mainz, August 2017 – On Aug. 24th Dr. Evan Newell from the Singapore Immunology Network (SIgN) in Singapore is visiting Mainz in the context of the Seminars in Translational Oncology (SITO).
Read More

Personalized RNA vaccine induces T cell responses in melanoma

Mainz, July 5th 2017 – Today, TRON and BioNTech AG announced the publication of Phase I clinical trial results in the renowned journal Nature.
Read More

Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Mainz, June 2017 – We are pleased to announce that our close cooperation partner BioNTech has today published an article in Nature Medicine. The paper entitled “Elimination of large tumors in mice by mRNA-encoded bispecific antibodies” reports preclinical data featuring their novel class of mRNA-encoded antibody drugs called RiboMABs® and describes the application of their
Read More

12. Run for Children 2017

Mainz, June 2017 – On June 10, TRON participated in the charity event „Run for Children®“.
Read More

2017 NMFZ prize awarded to Lena Kranz, PhD

Mainz, June 2017 – Lena Kranz, PhD, has been awarded for her doctoral thesis the 2017 NMFZ prize of the Natural Science and Medical Research Center Mainz (NMFZ), part of the University Medical Center of Mainz.
Read More

Lifetime achievement award to Cornelis Melief

Mainz, May 2017 – On May 10, 2017, Prof. Dr. Cornelis (Kees) Melief will be honored for life-time achievements in cancer immunotherapy research.
Read More

Mustafa Diken on the AACR conference 2017

Mainz, April – Mustafa Diken, PhD, presented on this year’s AACR conference 2017 our recent work on nanoparticles and RNA vaccine for cancer therapy.
Read More

Tracking the immune system with bioinformatic precision

Mainz, April – The 32nd Annual Meeting of the Rheumatology Working Group (ARRP) and the cooperative Rheumazentrum Rheinland-Pfalz e.V. …
Read More

7th Ci3-Cluster conference

Mainz, March 2017 – On March 14, 2017 the 7th Ci3-Cluster conference took place in Mainz. The conference looked back at the successes resulting from the past five years of funding for projects in the Cluster for Individualized ImmunIntervention (Ci3) via the German Ministry for Education and Research (BMBF).
Read More

Personalized Cancer Immunotherapy

Mainz, March 2017 – The Research Institute for Translational Oncology (TRON) and the German Cancer Research Center (DKFZ) in Heidelberg join forces in a newly founded Helmholtz Institute for Translational Oncology (HI-TRON) at the University Medical Center Mainz.
Read More

Special Issue Frontiers in Immunology

Mainz, 20. December 2016 – TRON scientists kick off special issue in Frontiers in Immunology. This is a call for papers to provide an up-to-date overview of current efforts to understand the immunological mechanisms of neoantigen directed T-cell immunity and the attempts to harvest this source of antigens for cancer immunotherapy. Read more about the
Read More

11 Fakten über Krebs

Mainz, 23. November 2016 – Wie entstehen Krebszellen? Ist Krebs erblich? Warum ist es so schwer, Krebs zu behandeln/zu heilen und welche neuen Ansätze zur Krebsbehandlung gibt es? Welche Rolle spielt dabei die individualisierte Immuntherapie – und was ist das überhaupt? TRON und BioNTech tragen 11 Fakten über Krebs zu “Wissen im Herzen” bei, eine
Read More

SITO – Seminars in Translational Oncology

Mainz, November 17 – ‘The immune biology of microsatellite instability cancer: Towards a vaccine against HNPCC’, Prof. von Knebel Doeberitz from the Institute of Pathology at the University of Heidelberg will speak in our seminar on Thursday during his visit at TRON.
Read More

SITO – Seminars in Translational Oncology

Mainz, November 10 – ‘Inducing Neoantigens in Therapeutic and Prophylactic Cancer Immunotherapy’, Prof. Eli Gilboa from the Sylvester Comprehensive Cancer Center at the University of Miami will speak in our seminar on Thursday during his visit at TRON.
Read More

SITO – Seminars in Translational Oncology

Mainz, September 29 – ‘Diabetes, beta-cells and reprogramming with mRNA: potential cell-based therapy for diabetes’ Tomáš Koblas of the Institute for Clinical and Experimental Medicine, Prague, will talk at Seminars in Translational Oncology (SITO) during his visit at TRON.
Read More

Author summary of our nature publication at ASGCT

Milwaukee, WI, July 23, 2016 – ‘A message for immunity: Systemic nanoparticle RNA vaccines mimic infection to fight cancer’, The American Society of Gene & Cell Therapy (ASGCT) publishes an author summary of our publication by Lena M. Kranz and colleagues in the renowned scientific journal Nature.
Read More

Lena M. Kranz speaks at PIVAC-16

Winchester, UK, September 13th – ” Systemic nanoparticle RNA vaccines mimic infection to fight cancer”, Lena M. Kranz will speak at the 16th International Conference on Progress in Vaccination Against Cancer (PIVAC-16), Session 5.
Read More

Ugur Sahin speaks at WCCS 2016

Vienna, September 01 2016 – TRON Scientific Manager Ugur Sahin will speak at the World Congress on Cancers of the Skin 2016. His talks will cover “Mutanome specific personalized vaccination” (11:30 a.m., 2016-09-01) and “RNA based mutanome specific vaccines – a true personalized therapy” (6:00 p.m., 2016-09-01).
Read More